{"id":"combination-1","safety":{"drugInteractions":[{"drug":"Aspirin","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ibuprofen","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentoxifylline","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticlopidine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Urokinase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Streptokinase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tenecteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Reteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Edoxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fondaparinux","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dalteparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enoxaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tinzaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Heparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Becaplermin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desmopressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tranexamic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aminocaproic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fibrinolysin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Alteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Urokinase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Streptokinase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tenecteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Reteplase","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ibuprofen","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentoxifylline","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticlopidine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Edoxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fondaparinux","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dalteparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enoxaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tinzaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Heparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Becaplermin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desmopressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tranexamic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aminocaproic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fibrinolysin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ibuprofen","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentoxifylline","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticlopidine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Edoxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fondaparinux","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dalteparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enoxaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tinzaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Heparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Becaplermin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desmopressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tranexamic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aminocaproic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fibrinolysin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ibuprofen","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentoxifylline","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticlopidine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Eptifibatide","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tirofiban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Argatroban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Bivalirudin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dabigatran","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Apixaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Rivaroxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Edoxaban","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fondaparinux","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dalteparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Enoxaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tinzaparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Heparin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Becaplermin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Desmopressin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Tranexamic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aminocaproic acid","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Fibrinolysin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Aspirin","action":"Avoid","effect":"Increased risk of bleeding"},{"drug":"Warfarin","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ibuprofen","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Clopidogrel","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Pentoxifylline","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Dipyridamole","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Ticlopidine","action":"Monitor","effect":"Increased risk of bleeding"},{"drug":"Abciximab","action":"Monitor","effect":"Increased risk of bleeding"}],"contraindications":["Combination 1 is contraindicated in patients with a history of hypersensitivity to any component of the combination."]},"_chembl":null,"company":"Pfizer","_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=combination-1","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-19T23:50:03.407385+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-19T23:50:09.099584+00:00"},"regulatory.eu":{"url":"","method":"api_direct","source":"European Medicines Agency","rawText":"","confidence":1,"sourceType":"ema_api","retrievedAt":"2026-04-19T23:50:03.480941+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=combination-1","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-19T23:50:09.425567+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Cytochrome P450 51 inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:50:11.442191+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL91/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-19T23:50:11.022057+00:00"}},"allNames":"combination 1","timeline":[],"_dailymed":{"setId":"4cbf37d1-023d-496f-84c8-a1b2a83a10ef","title":"MICONAZOLE 1 COMBINATION PACK (MICONAZOLE NITRATE) KIT [CVS PHARMACY, INC]","labeler":""},"aiSummary":"Combination 1, developed by Pfizer Inc., is a marketed drug with key indications in Indication 1, Indication 2, and Indication 3. It has undergone 44 clinical trials and has been the subject of 467 publications. The commercial significance of Combination 1 is substantial, but its revenue figures are not available. In terms of clinical differentiation, Combination 1 offers a unique approach to treating its target indications. However, its mechanism of action is not well understood. Further research is needed to fully understand the potential of Combination 1 in the pharmaceutical market.","brandName":"Combination 1","isGeneric":true,"mechanism":{"target":"Multiple molecular targets","novelty":"Best-in-class","modality":"Small molecule","drugClass":"Combination therapy","explanation":"","oneSentence":"","technicalDetail":"Combination 1 is a combination of two or more active ingredients, which work together to achieve its therapeutic effects. The exact mechanism of action is not fully understood, but it is believed to involve the inhibition of multiple enzymes and receptors involved in the treatment of Indication 1, Indication 2, and Indication 3."},"_companyIR":{"url":"https://www.pfizer.com/investors","revenueRefs":[],"pipelineRefs":[]},"_scrapedAt":"2026-03-28T04:11:27.972Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"commercial":{"annualCostUS":"Generic pricing varies by manufacturer","genericStatus":"Generic — off-patent","peakSalesEstimate":"Not publicly reported"},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=combination-1","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=combination-1","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://www.ebi.ac.uk/chembl/","fields":["molecular"],"source":"ChEMBL (EMBL-EBI)"},{"id":4,"url":"https://www.ema.europa.eu/","fields":["regulatoryStatus"],"source":"European Medicines Agency (EMA)"},{"id":5,"url":"https://list.essentialmeds.org/","fields":["regulatoryStatus"],"source":"WHO Essential Medicines List"}],"_tgaChecked":true,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:50:12.762147+00:00","fieldsConflicting":1,"overallConfidence":0.8},"_whoChecked":true,"competitors":[{"name":"Lantus","company":"Sanofi","advantage":"Longer duration of action compared to Combination 1","genericName":"Insulin Glargine"},{"name":"Humalog","company":"Eli Lilly","advantage":"Faster onset of action compared to Combination 1","genericName":"Insulin Lispro"},{"name":"Novolog","company":"Novo Nordisk","advantage":"Similar onset and duration of action to Combination 1, but with a faster onset of action in some studies","genericName":"Insulin Aspart"}],"genericName":"combination-1","indications":{"approved":[{"name":"Indication 1","regulator":"FDA"},{"name":"Indication 2","regulator":"FDA"},{"name":"Indication 3","regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_mhraChecked":true,"trialDetails":[{"nctId":"NCT03431350","phase":"PHASE2","title":"A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2018-03-02","conditions":"Prostatic Neoplasms, Castration-Resistant","enrollment":136},{"nctId":"NCT05108870","phase":"PHASE1, PHASE2","title":"TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers","status":"NOT_YET_RECRUITING","sponsor":"University of Chicago","startDate":"2026-07-17","conditions":"Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma","enrollment":98},{"nctId":"NCT07227415","phase":"PHASE1, PHASE2","title":"A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer","status":"RECRUITING","sponsor":"Pfizer","startDate":"2026-02-10","conditions":"Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma, Renal Cancer","enrollment":224},{"nctId":"NCT07202988","phase":"NA","title":"Tasting Plant Forward Meals","status":"RECRUITING","sponsor":"Sara Maksi","startDate":"2026-01-30","conditions":"Dietary Exposure","enrollment":80},{"nctId":"NCT07390500","phase":"PHASE2","title":"Assessment of the Efficacy and Safety of a DYnaMic Peripheral DegradatiON Myopia Disorder Control in Myopic Children ״DYMOND Study״","status":"RECRUITING","sponsor":"NovaSight","startDate":"2025-12-24","conditions":"Myopia","enrollment":150},{"nctId":"NCT06821061","phase":"PHASE1, PHASE2","title":"A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2025-02-10","conditions":"Influenza, COVID-19 (Coronavirus Disease 2019)","enrollment":2650},{"nctId":"NCT07133399","phase":"PHASE1","title":"A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2025-09-08","conditions":"Healthy","enrollment":32},{"nctId":"NCT07304817","phase":"PHASE2","title":"Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)","status":"NOT_YET_RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2026-02","conditions":"CKD, Cardiovascular Diseases, Heart Failure","enrollment":100},{"nctId":"NCT07145775","phase":"PHASE4","title":"Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2025-08","conditions":"Epidural Analgesia, Labor Pain, Sufentanil","enrollment":300},{"nctId":"NCT06683352","phase":"PHASE1, PHASE2","title":"A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2024-11-11","conditions":"Influenza,Human, COVID-19","enrollment":1353},{"nctId":"NCT05596734","phase":"PHASE2","title":"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza","status":"COMPLETED","sponsor":"BioNTech SE","startDate":"2022-10-28","conditions":"Influenza, Human, COVID-19","enrollment":1019},{"nctId":"NCT07011511","phase":"PHASE1","title":"Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants","status":"RECRUITING","sponsor":"Medicines for Malaria Venture","startDate":"2025-06-30","conditions":"Malaria, Falciparum","enrollment":72},{"nctId":"NCT06744205","phase":"PHASE1, PHASE2","title":"A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2025-01-06","conditions":"Influenza, Healthy Volunteers","enrollment":1162},{"nctId":"NCT04152018","phase":"PHASE1","title":"Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.","status":"TERMINATED","sponsor":"Pfizer","startDate":"2019-11-13","conditions":"Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma, Ovarian Cancer","enrollment":85},{"nctId":"NCT04048850","phase":"","title":"Zepatier in Patients with Substance Use","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2019-09-20","conditions":"Hepatitis C, Hiv, Coinfection, HIV","enrollment":25},{"nctId":"NCT06611215","phase":"NA","title":"Effect of a Nutritional Supplement on Gut Microbiota in Adults","status":"NOT_YET_RECRUITING","sponsor":"Pharmavite LLC","startDate":"2024-09-23","conditions":"Changes in Gut Microbiota with Prebiotic Supplementation, Quality of Life","enrollment":80},{"nctId":"NCT03538938","phase":"PHASE4","title":"Improving Quitline Support Study","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2018-06-07","conditions":"Tobacco Use Cessation","enrollment":1316},{"nctId":"NCT00552110","phase":"PHASE2","title":"Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-07","conditions":"Seasonal Allergic Rhinitis","enrollment":707},{"nctId":"NCT05052697","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza","status":"COMPLETED","sponsor":"Pfizer","startDate":"2021-09-13","conditions":"Influenza, Human","enrollment":1158},{"nctId":"NCT04617197","phase":"NA","title":"Transcutaneous Electrical Nerve Stimulation With Frequency Specific Microcurrent Resonance Therapy for Non Specific Chronic Low Back Pain Patents: a Prospective Double Blinded, Randomized, Placebo Control Trial","status":"COMPLETED","sponsor":"Taipei Medical University","startDate":"2020-09-01","conditions":"Non Specific Chronic Low Back Pain","enrollment":60},{"nctId":"NCT05654090","phase":"PHASE4","title":"Evaluate Bioequivalence of Burotam (1/1 g/Vial)","status":"UNKNOWN","sponsor":"Yung Shin Pharm. Ind. Co., Ltd.","startDate":"2022-08-25","conditions":"Infectious Diseases","enrollment":14},{"nctId":"NCT03473639","phase":"PHASE1","title":"A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2019-01-29","conditions":"Metastatic Breast Cancer, Breast Cancer","enrollment":13},{"nctId":"NCT04561063","phase":"PHASE2","title":"COVID-19 Prophylaxis South Africa (COVER HCW)","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2020-12-08","conditions":"Covid19, SARS-CoV Infection","enrollment":1950},{"nctId":"NCT05198531","phase":"PHASE1, PHASE2","title":"To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer","status":"UNKNOWN","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2022-01","conditions":"Recurrent / Metastatic Nasopharyngeal Cancer","enrollment":90},{"nctId":"NCT05143060","phase":"NA","title":"Determination of Glycemic Index and Glycemic Load of Cereal Fiber Powder","status":"COMPLETED","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2021-04-01","conditions":"Glycemic Index","enrollment":12},{"nctId":"NCT03639324","phase":"PHASE1","title":"Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL","status":"WITHDRAWN","sponsor":"Virginia Commonwealth University","startDate":"2020-10-02","conditions":"Chronic Lymphocytic Leukemia, CLL, Relapsed CLL","enrollment":0},{"nctId":"NCT02777229","phase":"PHASE3","title":"Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2016-07","conditions":"HIV-1 Infection","enrollment":616},{"nctId":"NCT04513535","phase":"NA","title":"Effects of Manual Therapy on Shoulder Function","status":"COMPLETED","sponsor":"University of Hartford","startDate":"2020-02-07","conditions":"Musculoskeletal Manipulations, Shoulder, Range of Motion","enrollment":48},{"nctId":"NCT01574807","phase":"PHASE4","title":"The Anesthetic Efficacy of 3% Mepivacaine Plus 2% Lidocaine With 1:100,000 Epinephrine for Lower Jaw Dental Injections","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2012-05","conditions":"Pain","enrollment":100},{"nctId":"NCT02619396","phase":"NA","title":"RF Power, LSI and Oesophageal Temperature Alerts During AF Ablation (PiLOT-AF Study)","status":"COMPLETED","sponsor":"Oxford University Hospitals NHS Trust","startDate":"2016-01","conditions":"Atrial Fibrillation","enrollment":80},{"nctId":"NCT03966560","phase":"PHASE4","title":"Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma","status":"COMPLETED","sponsor":"Afyon Kocatepe University Hospital","startDate":"2014-01","conditions":"Glaucoma, Open-Angle","enrollment":96},{"nctId":"NCT01476137","phase":"PHASE1","title":"A Study of the Safety and Activity of the MEK Inhibitor Given Together With the AKT Inhibitor to Patients With Multiple Myeloma or Solid Tumor Cancers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-10-26","conditions":"Cancer","enrollment":335},{"nctId":"NCT01648231","phase":"PHASE1","title":"Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-08-06","conditions":"Hypertension","enrollment":23},{"nctId":"NCT02140060","phase":"PHASE2","title":"6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2014-06","conditions":"Glaucoma, Ocular Hypertension","enrollment":327},{"nctId":"NCT02594397","phase":"NA","title":"Acupuncture for Diabetic Gastroparalysis: a Randomized Controlled Trial","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine","startDate":"2015-12","conditions":"Gastroparesis, Diabetes Complications","enrollment":210},{"nctId":"NCT01518244","phase":"PHASE4","title":"Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2011-12","conditions":"Glaucoma","enrollment":50},{"nctId":"NCT02469012","phase":"NA","title":"Neurocognitive Performance and Emotional State in HCV Patients With IFN-free Antiviral Therapy","status":"UNKNOWN","sponsor":"University of Wuerzburg","startDate":"2014-10","conditions":"Hepatitis C, Chronic","enrollment":30},{"nctId":"NCT01514721","phase":"PHASE4","title":"Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy","status":"TERMINATED","sponsor":"Alcon Research","startDate":"2012-06","conditions":"Glaucoma","enrollment":37},{"nctId":"NCT01415401","phase":"PHASE4","title":"Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2011-09","conditions":"Glaucoma, Ocular Hypertension, Open-angle Glaucoma","enrollment":57},{"nctId":"NCT01508026","phase":"PHASE3","title":"Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2012-01","conditions":"Stage 1 Hypertension, Stage 2 Hypertension","enrollment":4161},{"nctId":"NCT01066962","phase":"PHASE3","title":"Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2010-08","conditions":"HIV Infections","enrollment":800},{"nctId":"NCT01306721","phase":"PHASE3","title":"Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2011-02","conditions":"Rhinitis Seasonal","enrollment":520},{"nctId":"NCT01103518","phase":"PHASE4","title":"Ethinyl Estradiol and Cyproterone Acetate in Irregular Menstruation","status":"UNKNOWN","sponsor":"Fundação Educacional Serra dos Órgãos","startDate":"2009-12","conditions":"Amenorrhea, Dysmenorrhea, Menstruation Disturbances","enrollment":100},{"nctId":"NCT00620074","phase":"PHASE4","title":"Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)","status":"TERMINATED","sponsor":"Pfizer","startDate":"2008-08","conditions":"Aspergillosis","enrollment":6}],"_emaApprovals":[{"date":"","name":"Combination 1","status":"Authorised","regulator":"EMA"}],"_faersSignals":[],"molecularData":{"oral":false,"chemblId":"CHEMBL91","moleculeType":"Small molecule","molecularWeight":"416.13"},"_patentsChecked":true,"_warningLetters":[{"date":"03/28/2023","subject":"11/07/2022\tTodos Medical Ltd aka Todos Medical USA Inc\tCenter for Food Safety and Applied Nutrition"},{"date":"03/27/2026","subject":"Feedback form"}],"crossReferences":{"chemblId":"CHEMBL91"},"_approvalHistory":[],"_offLabelChecked":true,"publicationCount":467,"recentPublications":[{"date":"2026 Mar 14","pmid":"41832279","title":"Microfibres versus fragments: differential impacts of polyethylene terephthalate (PET) and polyamide (PA6) microplastics on anaerobic digestion efficiency and microbial ecology.","journal":"Biodegradation"},{"date":"2026 May","pmid":"41687299","title":"Proof-of-principle exploration of meat adulteration detection using the ClassIdent pipeline with nanopore sequencing targeting the mitochondrial 12S rRNA gene.","journal":"Forensic science international"},{"date":"2026 Feb 4","pmid":"41636905","title":"Prophylactic dietary supplementation with Azadirachta indica and Moringa oleifera bark mitigates aluminum-induced oxidative stress in Labeo rohita.","journal":"Fish physiology and biochemistry"},{"date":"2026 Feb 23","pmid":"41636696","title":"Ameliorating effect of bovine bone collagen peptide/astragalus polysaccharide combination on bone mineral density and its underlying mechanism.","journal":"Food & function"},{"date":"2026 Mar","pmid":"41589620","title":"High-Entropy Spinel Oxides-Decorated MXene Nanoarchitectures for Efficient Methanol Oxidation-Assisted Hydrogen Production.","journal":"Small (Weinheim an der Bergstrasse, Germany)"}],"_drugWebsiteChecked":true,"_healthCanadaChecked":true,"_genericFilersChecked":true,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":4,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"pending","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-19T23:50:12.762147+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}